An Incisive, In-depth Analysis on the Appendage Management Market
This study offers a comprehensive, 360 degree analysis on the Appendage Management market, bringing to fore insights that can help stakeholders identify the opportunities as well as challenges. It tracks the global Appendage Management market across key regions, and offers in-depth commentary and accurate quantitative insights. The study also includes incisive competitive landscape analysis, and provides key recommendations to market players on winning imperatives and successful strategies.
50% Revenue Contribution by the Leading Manufacturers
The appendage management market is mainly dominated by the key players and they are competing on the basis of minimally closure approaches, epicardial and endocardial site of the device implantation along with additional favorable features in the market. The dominating companies, for instance, Boston Scientific Corporation and AtriCure, Inc., hold above 50% share in the terms of revenue in the global appendage management market. Both the companies are constantly making efforts to launch innovative products for appendage management and have published numerous results from clinical trials to support the sale of the devices. Additionally, Boston Scientific Corporation and AtriCure, Inc. operating in the appendage management market are focusing on collaborations and partnerships with local distributors to increase their supply chain and penetration of their products in the appendage management market. Some of the devices are yet to receive approval to permit sale and use of the device in some countries and this restricts the influence of other companies in the appendage management market. However, growing number of clinical trials and launch of new innovative products along with generation of huge product portfolio for appendage management have increased the opportunities for the global manufacturers.
Reduced Risk of Stroke and Atrial Fibrillation upon Use of Left Atrial Appendage Closure Device
The prevalence of atrial fibrillation is observed to be constantly increasing and is further expected to grow with greater speed. The risk of stroke in individual with atrial fibrillation is multiplied and this creates a threat. The necessity of treatment options for appendage management and to cure atrial fibrillation is thus very high. Traditionally, oral anticoagulants drugs and blood thinners are used to inhibit blood clot formation in the left atrial appendage, however, with the advancements in medical science and technology, LAA closure devices can be considered potential appendage management alternative to treat atrial fibrillation. Epicardial and Endocardial LAA closure devices are ruled safe and efficient from the clinical trials and approved for sale and implantation.
Minimally Invasive Nature & Non-surgical Approach of Procedure Reduces Complications
The heart and the structures related to it are very delicate and vital. The demand for minimally invasive surgeries is growing due to reduced complications and greater precision. The implantation of the left atrial appendage closure device is a minimally invasive procedure. Stent procedure includes insertion of the device in the body and navigating to the desired location through visualization feature. Such technological aspects enable great precision, accuracy and efficient implantation of the device. Treatment of atrial fibrillation through minimally invasive approach propels the demand for left atrial appendage closure devices in the appendage management market.
Alternate to Anticoagulant Drugs and Low Risk of Side Effects
Anticoagulant drugs are traditionally used in appendage management to inhibit blood clot formation in the left atrial appendage which leads to stroke. Anticoagulant drugs need regular check-ups to ensure the right action of the drugs in the required amount. This requires constant clinic or hospital visits. Moreover, these drugs hold a long list of side-effects which may be fatal. Governments are taking various initiatives to spread awareness about the adverse effects of taking anticoagulant drugs. In this scenario, left atrial appendage closure devices steal the spotlight. Left atrial appendage closure devices are safe with no side-effects. Additionally, it is one time procedure and the long-term cost of implantation of left atrial appendage closure device is calculated to be less than that of anticoagulant drugs. This becomes an important factor to drive the growth of left atrial appendage closure devices in the appendage management market.
Growing Geriatric Population Propels the Demand for Appendage Management
Atrial fibrillation is significantly prevalent in the elder population, aged 65 and above. Around 70% of people suffering from atrial fibrillation are 65–85 years of age. Therefore, growing geriatric population is considered an important factor driving the growth of the appendage management market. Atrial fibrillation is estimated to rise the incidence rate exponentially in the future. With the increasing product approvals in the appendage management market, more and more people are expected to implant the left atrial appendage closure devices to eliminate or reduce the risk of stroke.
This section of the report features profiles of key players operating in the appendage management market based on their market shares, differential strategies, product offerings, marketing approach and company dashboard. Some of the key players featured in this report include Abbott Laboratories, AtriCure, Inc., Boston Scientific Corporation, Cardia, Inc., Johnson & Johnson Services, Inc., LifeTech Scientific Co., Ltd, Medtronic plc., SentreHEART, Inc., Occlutech International AB.
Boston Scientific Corporation offers the most trusted product for appendage management, named WATCHMAN device. WATCHMAN device is an endocardial left atrial appendage closure device for occlusion of left atrial appendage. Boston Scientific is launching next-generation WATCHMAN devices with improved and additional features to continue domination in appendage management market.
The key manufacturers of appendage management are focusing on acquisitions and mergers to extend their product portfolio. Launching of new and innovative products is also a strategy followed by the players that is working in their favor. The companies are conducting conferences and training sessions in hospitals and institutes to enlighten surgeons and practitioners with the improved technology and novel product left atrial appendage closure devices in the appendage management market.
Left atrial appendage closure devices perform the function of ceasing the blood flow to the left atrial appendage, which is like a chamber giving rise to a condition called as atrial fibrillation. In atrial fibrillation, the normal pumping rhythm of the heart is disturbed and blood clots are formed at the left atrial appendage which may be later circulated to vital organs and may lead to stroke. The report focuses on the products and devices used to close and manage the left atrial appendage and eliminate the risks associated with it.
About the Report
FMI conducted a research study on the appendage management market for the forecast period 2018 to 2022. The appendage management market report offers a comprehensive evaluation of the business opportunities prevailing in the appendage management market along with insights on the appendage management trend, disease incidences, and awareness level for appendage management and appendage management market competition. The report elaborates the macroeconomic factors influencing the dynamics of the appendage management market and its futuristic potential.
The report offers a comprehensive taxonomy of the appendage management market based on product type, end user and region. The appendage management market is categorized into two types of products that are epicardial LAA closure devices and endocardial LAA closure devices. These mechanical closure devices in appendage management are used by catheterization and hospitals for appendage management. Thus, the end-use segments in appendage management market which are a part of this appendage management market report include catheterization laboratories and hospitals. The appendage management market has been analyzed across regions of North America, Latin America, Europe, Asia Pacific (APAC), and MEA.
Additional Questions Answered
Some of the additional questions addressed in this report on appendage management market-
What is the revenue potential of epicardial and endocardial left atrial appendage closure device in appendage management market across regions of North America and Europe?
Who are the key competitors and what are their portfolios in appendage management market?
What are major challenges influencing the growth of appendage management market?
How intervention from regulatory authority is shaping the appendage management market growth?
The appendage management market has been estimated based on supply-demand approach. The market was first calculated based on implantation of LAA closure devices volume conducted in different region/countries. The test volume was estimated based on the incidence rate of atrial fibrillation in top 20 countries globally. Other qualitative factors analyzed during test volume estimation include awareness level for appendage management, incidence rate of atrial fibrillation and others. This information is further validated with rigorous primary research (including interviews, surveys, in-person interactions, and viewpoints of seasoned analysts) and secondary research (including verified paid sources, authentic trade journals, and resourceful databases). The research study on appendage management market also includes top trends and macro as well as micro economic factors shaping the appendage management market. With this approach, the report on appendage management market anticipates the industry attractiveness of every major segment in appendage management over the forecast period.
A recent market study published by FMI – “Appendage Management Market: Global Industry Analysis 2013–2017 & Opportunity Assessment 2018–2028” – consists a comprehensive assessment of the most important market dynamics. On conducting a thorough research on the historic as well as current growth parameters of the appendage management market, growth prospects of the market are obtained with maximum precision. The report features unique and salient factors that may have a huge impact on the development of the appendage management market during the forecast period. It can help market players to modify their manufacturing and marketing strategies to envisage maximum growth in the appendage management market in the upcoming years. The report provides detailed information about the current and future growth prospects of the appendage management market in the most comprehensive way for the better understanding of readers.
Chapter 1 – Executive Summary
The report commences with the executive summary of the appendage management market, which includes the summary of key findings and key statistics of the market. It also includes the market value (US$ million) estimates of the leading segments of the appendage management market.
Chapter 2 – Market Overview
Readers can find detailed taxonomy and the definition of the appendage management market in this chapter, which will help readers to understand the basic information about the appendage management market dynamics, supply chain, cost structure, pricing analysis, list of key distributor and suppliers, list of key market participants included in the report.
Chapter 3 – Global Appendage Management Market Analysis 2013–2017 & Opportunity Assessment 2018–2028, By Product Type
Based on the product type, the appendage management market is segmented into Epicardial LAA closure devices and Endocardial LAA closure devices. In this chapter, readers can find information about key trends and developments in the appendage management market and market attractive analysis based on the product type, epicardial and endocardial LAA closure devices.
Chapter 4 – Global Appendage Management Market Analysis 2013–2017 & Opportunity Assessment 2018–2028, By End User
Based on the End User, the appendage management market is segmented into diagnostic laboratories, hospitals, academic research institutes and other end users. In this chapter, readers can find information about key trends and developments in the appendage management market and market attractive analysis based on end user.
Chapter 5 – Global Appendage Management Market Analysis 2013–2017 & Opportunity Assessment 2018–2028, By Region
This chapter explains how the appendage management market will grow across various geographic regions, such as North America, Latin America, Europe, Asia-Pacific (APAC), and the Middle East & Africa (MEA).
Chapter 6 – North America Appendage Management Market Analysis 2013–2017 & Opportunity Assessment 2018–2028
This chapter includes detailed analysis of the growth of the North America Appendage Management market along with the country-wise assessment including the U.S. and Canada. Readers can also find regional trends, regulations, and market growth based on product type and countries in the North America appendage management market.
Chapter 7 – Latin America Appendage Management Market Analysis 2013–2017 & Opportunity Assessment 2018–2028
Readers can find detailed information about factors such as, pricing analysis, and regional trends that are impacting the growth of the Latin America Appendage Management market. This chapter also includes the growth prospects of the Appendage Management market in leading LATAM countries such as Brazil, Mexico, and Rest of Latin America.
Chapter 8 – Europe Appendage Management Market Analysis 2013–2017 & Opportunity Assessment 2018–2028
Important growth prospects of the appendage management market based on its product types, form, and applications in several European countries, such as Germany, U.K., France, Italy, Spain, Russia, Poland, and Rest of Europe is included in this chapter.
Chapter 9 – APAC Appendage Management Market Analysis 2013–2017 & Opportunity Assessment 2018–2028
China, India, Australia, ASEAN, Japan, and Rest of APAC are the leading countries in the APAC region that are the prime subject of assessment to obtain growth prospects of the APAC appendage management market in this chapter. Readers can find thorough information about the growth parameters of the APAC appendage management market during the period 2018–2028.
Chapter 10 – MEA Appendage Management Market Analysis 2013–2017 & Opportunity Assessment 2018–2028
This chapter provides information on how the appendage management market will grow in the major countries in MEA region, such as GCC Countries, South Africa, and Rest of MEA during the period 2018–2028.
Chapter 11 – Competition Landscape, Company Share and Company Profiles
In this chapter, readers can find a comprehensive list of all the leading stakeholders in the Appendage Management market along with detailed information about each company, including company overview, revenue shares, strategic overview, and recent company developments. Market players featured in the report include Abbott Laboratories, AtriCure, Inc., Boston Scientific Corporation, Cardia, Inc., Johnson & Johnson Services, Inc., LifeTech Scientific Co., Ltd, Medtronic plc., SentreHEART, Inc., Occlutech International AB.
Chapter 12 – Assumptions and Acronyms
This chapter includes a list of acronyms and assumptions that provide a base to the information and statistics included in the report.
Chapter 13 – Research Methodology
This chapter helps readers to understand the research methodology followed to obtain various conclusions, important qualitative information, and quantitative information about the appendage management market.